Granulocyte colony‐stimulating factor‐producing melanoma treated with the combination of dabrafenib and trametinib

Saved in:
Bibliographic Details
Published inInternational journal of dermatology Vol. 57; no. 7; pp. e31 - e33
Main Authors Minowa, T., Kato, J., Hida, T., Horimoto, K., Sato, S., Sawada, M., Takahashi, H., Uhara, H.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.07.2018
Subjects
Aged
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Fatal Outcome
Granulocyte Colony-Stimulating Factor - metabolism
Head and Neck Neoplasms - drug therapy
Head and Neck Neoplasms - metabolism
Head and Neck Neoplasms - pathology
Humans
Imidazoles - administration & dosage
Leukocytes (granulocytic)
Male
Melanoma
Melanoma - drug therapy
Melanoma - metabolism
Melanoma - secondary
Oximes - administration & dosage
Pyridones - administration & dosage
Pyrimidinones - administration & dosage
Scalp
Skin Neoplasms - drug therapy
Skin Neoplasms - metabolism
Skin Neoplasms - pathology
Online AccessGet full text

Cover

More Information
ISSN:0011-9059
1365-4632
DOI:10.1111/ijd.14004